Iovance Biotherapeutics Inc (IOVA)’s stock has witnessed a price hike of 17.67% from the previous close with its current price standing at $2.93. Its current price is -76.57% under its 52-week high of $12.51 and 78.82% more than its 52-week low of $1.64.
The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, IOVA’s SMA-200 is $5.39.
Additionally, it is important to take into account IOVA stock ratios, including its price-to-sales ratio, which is 4.60 for the last tewlve months.IOVA’s price to book ratio for the most recent quarter was 1.27, resulting in an 2.72 price to cash per share for the period.
How does Iovance Biotherapeutics Inc (IOVA) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1.
Iovance Biotherapeutics Inc (NASDAQ: IOVA) Ownership Details
I will give a breakdown of the key shareholders in Iovance Biotherapeutics Inc (IOVA). Recent figures show that the company’s insiders hold 0.37% of shares. A total of 391 institutional investors hold shares in the company, making 81.26% of its stock and 81.57% of its float.
Mar 31, 2025 , it was reported that the Company’s largest institutional holder is Vanguard Group Inc holding total of 27.78 shares that make 8.32% of the company’s total number of shares and are currently priced at 81.11 million.
The securities firm MHR Fund Management, LLC holds 24.42 shares of IOVA, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 7.31% , and the holding percentage of shares is valued at 71.3 million.
An overview of Iovance Biotherapeutics Inc’s technicals
In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Iovance Biotherapeutics Inc (IOVA) traded 15,099,334 shares per day, with a moving average of $1.97 and price change of +1.04. With the moving average of $1.93 and a price change of -0.28, about 16,201,775 shares changed hands on average over the past 50 days. Finally, IOVA’s 100-day average volume is 13,553,825 shares, alongside a moving average of $2.71 and a price change of -2.46.
